Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044164 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Indu Sinha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, PA 17033, USA. Hauptthemen laut MEDLINE: Saliva, Breast Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Cancer Control Program at the Penn State Cancer Institute.
Abstract (Originalsprache)
Breast cancer is the second leading cause of death for women in the United States, and early detection could offer patients the opportunity to receive early intervention. The current methods of diagnosis rely on mammograms and have relatively high rates of false positivity, causing anxiety in patients. We sought to identify protein markers in saliva and serum for early detection of breast cancer. A rigorous analysis was performed for individual saliva and serum samples from women without breast disease, and women diagnosed with benign or malignant breast disease, using isobaric tags for relative and absolute quantitation (iTRAQ) technique, and employing a random effects model. A total of 591 and 371 proteins were identified in saliva and serum samples from the same individuals, respectively. The differentially expressed proteins were mainly involved in exocytosis, secretion, immune response, neutrophil-mediated immunity and cytokine-mediated signaling pathway. Using a network biology approach, significantly expressed proteins in both biological fluids were evaluated for protein–protein interaction networks and further analyzed for these being potential biomarkers in breast cancer diagnosis and prognosis. Our systems approach illustrates a feasible platform for investigating the responsive proteomic profile in benign and malignant breast disease using saliva and serum from the same women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, PA 17033, USA.
- Environmental Science and Sustainability Program, Harrisburg University of Science and Technology, Harrisburg, PA 17101, USA.
- Department of Bioengineering, Marmara University, Istanbul 34854, Turkey.
- Mass Spectrometry Core, Penn State University College of Medicine, Hershey, PA 17033, USA.
- Department of Public Health Sciences, Penn State University College of Medicine, Hershey, PA 17033, USA.
- Department of Health Policy and Administration, The Pennsylvania State University, University Park, State College, PA 16801, USA.
ORCID-Profile: Rachel L Fogle, Gizem Gulfidan, Vonn Walter, Christopher S Hollenbeak, Kazim Y Arga, Raghu Sinha
Förderung
- NCATS NIH HHS
- Cancer Control Program at the Penn State Cancer Institute
Zitieren
APA
Sinha, I., Fogle, R. L., Gulfidan, G., Stanley, A. E., Walter, V., Hollenbeak, C. S., Arga, K. Y., & Sinha, R. (2023). Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044164
Vancouver
Sinha I, Fogle RL, Gulfidan G, Stanley AE, Walter V, Hollenbeak CS, et al. Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044164
BibTeX
@article{Sinha2023,
author = {Sinha, Indu and Fogle, Rachel L and Gulfidan, Gizem and Stanley, Anne E and Walter, Vonn and Hollenbeak, Christopher S and Arga, Kazim Y and Sinha, Raghu},
title = {Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044164}
}
EUVIMED